JP2023502398A5 - - Google Patents
Info
- Publication number
- JP2023502398A5 JP2023502398A5 JP2022529066A JP2022529066A JP2023502398A5 JP 2023502398 A5 JP2023502398 A5 JP 2023502398A5 JP 2022529066 A JP2022529066 A JP 2022529066A JP 2022529066 A JP2022529066 A JP 2022529066A JP 2023502398 A5 JP2023502398 A5 JP 2023502398A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962937395P | 2019-11-19 | 2019-11-19 | |
| US62/937,395 | 2019-11-19 | ||
| PCT/US2020/061028 WO2021101975A1 (en) | 2019-11-19 | 2020-11-18 | Methods of treating warm autoimmune hemolytic anemia using anti-fcrn antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502398A JP2023502398A (ja) | 2023-01-24 |
| JP2023502398A5 true JP2023502398A5 (https=) | 2023-11-15 |
| JP7722991B2 JP7722991B2 (ja) | 2025-08-13 |
Family
ID=73854886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529066A Active JP7722991B2 (ja) | 2019-11-19 | 2020-11-18 | 抗ｆｃｒｎ抗体を用いた温熱自己免疫性溶血性貧血の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230049011A1 (https=) |
| EP (1) | EP4061486A1 (https=) |
| JP (1) | JP7722991B2 (https=) |
| KR (1) | KR20220100880A (https=) |
| CN (1) | CN114728180A (https=) |
| AU (1) | AU2020387399A1 (https=) |
| CA (1) | CA3157797A1 (https=) |
| IL (1) | IL292889A (https=) |
| MX (1) | MX2022005862A (https=) |
| TW (1) | TW202132346A (https=) |
| WO (1) | WO2021101975A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7755725B2 (ja) * | 2021-08-13 | 2025-10-16 | ジャンスー バイオジェッテイ バイオテクノロジー カンパニー リミテッド | Ｆｃｒｎを特異的に認識する抗体およびその使用 |
| AU2023281650A1 (en) | 2022-05-30 | 2024-10-17 | Hanall Biopharma Co., Ltd. | Anti-fcrn antibody or antigen binding fragment thereof with improved stability |
| WO2024052357A1 (en) * | 2022-09-06 | 2024-03-14 | Immunovant Sciences Gmbh | Methods of treating graves' disease using anti-fcrn antibodies |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3137504T3 (pl) * | 2014-04-30 | 2023-10-16 | Hanall Biopharma Co., Ltd. | Przeciwciało wiążące się z FcRn do leczenia chorób autoimmunologicznych |
| US10336825B2 (en) * | 2014-04-30 | 2019-07-02 | Hanall Biopharma Co., Ltd. | Antibody binding to FcRn for treating autoimmune diseases |
| RS64768B1 (sr) * | 2015-01-30 | 2023-11-30 | Momenta Pharmaceuticals Inc | Fcrn antitela i načini njihove upotrebe |
| EP3294335B1 (en) * | 2015-05-12 | 2023-07-05 | Syntimmune Inc. | Humanized affinity matured anti-fcrn antibodies |
| SMT202400004T1 (it) * | 2016-07-29 | 2024-03-13 | Momenta Pharmaceuticals Inc | Anticorpi fcrn e loro metodi di utilizzo |
| WO2019160979A1 (en) * | 2018-02-13 | 2019-08-22 | The Brigham And Women's Hospital, Inc. | Therapeutic fcrn-based bispecific monoclonal antibodies |
-
2020
- 2020-11-18 AU AU2020387399A patent/AU2020387399A1/en not_active Abandoned
- 2020-11-18 MX MX2022005862A patent/MX2022005862A/es unknown
- 2020-11-18 CA CA3157797A patent/CA3157797A1/en active Pending
- 2020-11-18 IL IL292889A patent/IL292889A/en unknown
- 2020-11-18 US US17/777,913 patent/US20230049011A1/en active Pending
- 2020-11-18 CN CN202080080573.3A patent/CN114728180A/zh active Pending
- 2020-11-18 TW TW109140405A patent/TW202132346A/zh unknown
- 2020-11-18 WO PCT/US2020/061028 patent/WO2021101975A1/en not_active Ceased
- 2020-11-18 EP EP20825291.6A patent/EP4061486A1/en active Pending
- 2020-11-18 JP JP2022529066A patent/JP7722991B2/ja active Active
- 2020-11-18 KR KR1020227016333A patent/KR20220100880A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (https=) | ||
| JP2024016177A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| JP2022532927A5 (https=) | ||
| JP2017160208A5 (https=) | ||
| JP2023502398A5 (https=) | ||
| JP2020509027A5 (https=) | ||
| RU2016130056A (ru) | Способы лечения кожной инфекции путем введения антагониста il-4r | |
| JP2008528638A5 (https=) | ||
| RU2012131547A (ru) | Антитела человека против ангиопоэтин-подобного белка 4 человека | |
| CN114762678B (zh) | 抗tigit抗体药物组合物及其用途 | |
| JP2021532126A5 (https=) | ||
| JP2023541858A5 (https=) | ||
| PE20212185A1 (es) | Formulacion de anticuerpos terapeuticos | |
| JP2024515968A5 (https=) | ||
| JP2024533067A5 (https=) | ||
| JP2025503614A5 (https=) | ||
| JP2021531732A5 (https=) | ||
| JP2019512472A5 (https=) | ||
| JP2024544523A5 (https=) | ||
| MX2024001326A (es) | Composicion farmaceutica de anticuerpo anti-pd-1 y uso de la misma. | |
| JP2024540226A5 (https=) | ||
| JP2024527607A5 (https=) | ||
| JP2025500784A5 (https=) | ||
| JP2021523138A5 (https=) |